Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients

Hepatology Research

Volumn 44, Issue 3, 2014, Pages 280-287

  Takaki, Shintaro ^a   Kawakami, Yoshiiku ^a   Miyaki, Daisuke ^a   Nakahara, Takashi ^a   Naeshiro, Noriaki ^a   Murakami, Eisuke ^a   Tanaka, Mio ^a   Honda, Yohji ^a   Yokoyama, Satoe ^a   Nagaoki, Yuko ^a   Kawaoka, Tomokazu ^a   Hiramatsu, Akira ^a   Tsuge, Masataka ^a   Hiraga, Nobuhiko ^a   Imamura, Michio ^a   Hyogo, Hideyuki ^a   Aikata, Hiroshi ^a   Takahashi, Shoichi ^a   Arihiro, Koji ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acoustic radiation force impulse; Elastography; Hepatitis C; Index; Liver fibrosis; Virtual touch tissue quantification

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 84895159656     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12129     Document Type: Article

References (25)

1. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15: 5-14.
2. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832.
3. Tomimatsu M, Ishiguro N, Taniai M etal. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993; 72: 683-688.
4. Ikeda K, Sitoh S, Koida I etal. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
5. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995; 21: 650-655.
6. Shiratori Y, Shiina S, Imamura M etal. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 1995; 22: 1027-1033.
7. Ikeda K, Arase Y, Kobayashi M etal. Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis. J Gastroenterol 2003; 38: 865-876.
8. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology 2011; 53: 325-335.
9. Wai CT, Greenson JK, Fontana RJ etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
10. Sterling RK, Lissen E, Clumeck N etal. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317-1325.
11. Adams LA, Bulsara M, Rossi E etal. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51: 1867-1873.
12. Forns X, Ampurdanes S, Llovet JM etal. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-992.
13. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Fibro MY. Index, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007; 45: 297-306.
14. Cales P, Oberti F, Michalak S etal. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005; 42: 1373-1381.
15. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
16. Kettaneh A, Marcellin P, Douvin C etal. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007; 46: 628-634.
17. Ganne-Carrie N, Ziol M, de Ledinghen V etal. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-1517.
18. Castera L, Vergniol J, Foucher J etal. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
19. Friedrich-Rust M, Ong MF, Herrmann E etal. Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007; 188: 758-764.
20. Koizumi Y, Hirooka M, Kisaka Y etal. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography - establishment of the method for measurement. Radiology 2011; 258: 610-617.
21. Friedrich-Rust M, Wunder K, Kriener S etal. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009; 252: 595-604.
22. Takahashi H, Ono N, Eguchi Y etal. Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int 2010; 30: 538-545.
23. Yoneda M, Suzuki K, Kato S etal. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 2010; 256: 640-647.
24. Lupsor M, Badea R, Stefanescu H etal. Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C. Preliminary results. J Gastrointestin Liver Dis 2009; 18: 303-310.
25. Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. King's Score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2009; 21: 730-738.